A business in context
INCY research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 3148.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 2072.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 9459.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 2623.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 2864.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 1643.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 3023.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 2623.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 1642.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 2293.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 85.0 | 0.0 |
| 2026-07-31 | Mayes Patrick A | M · Exercise / conversion | Employee Stock Option (right to buy) | 326.0 | 0.0 |
| 2026-07-31 | CAGNONI PABLO J | S · Sale | Common Stock | 15888.0 | 119.7 |
| 2026-07-23 | Heeson Lee | A · Grant / award | Employee Stock Option (right to buy) | 15423.0 | 0.0 |
| 2026-07-23 | Heeson Lee | A · Grant / award | Performance Shares | 13498.0 | 0.0 |
| 2026-07-23 | Morrissey Michael James | A · Grant / award | Employee Stock Option (right to buy) | 6426.0 | 0.0 |
| 2026-07-23 | Morrissey Michael James | A · Grant / award | Performance Shares | 8999.0 | 0.0 |
| 2026-07-16 | Hoffman Richard A. | A · Grant / award | Common Stock | 7395.0 | 0.0 |
| 2026-07-16 | Hoffman Richard A. | A · Grant / award | Performance Shares | 18487.0 | 0.0 |
| 2026-07-16 | Hoffman Richard A. | A · Grant / award | Employee Stock Option (right to buy) | 31923.0 | 0.0 |
| 2026-07-16 | Gardner David H | A · Grant / award | Common Stock | 7395.0 | 0.0 |
| 2026-07-16 | Gardner David H | A · Grant / award | Performance Shares | 18487.0 | 0.0 |
| 2026-07-16 | Gardner David H | A · Grant / award | Employee Stock Option (right to buy) | 31923.0 | 0.0 |
| 2026-07-16 | Basi Ramitpal K | A · Grant / award | Common Stock | 4991.0 | 0.0 |
| 2026-07-16 | Basi Ramitpal K | A · Grant / award | Employee Stock Option (right to buy) | 21548.0 | 0.0 |
| 2026-07-16 | Basi Ramitpal K | A · Grant / award | Performance Shares | 12479.0 | 0.0 |
| 2026-07-16 | Mayes Patrick A | A · Grant / award | Common Stock | 5916.0 | 0.0 |
| 2026-07-16 | Mayes Patrick A | A · Grant / award | Employee Stock Option (right to buy) | 25538.0 | 0.0 |
| 2026-07-16 | Mayes Patrick A | A · Grant / award | Performance Shares | 14790.0 | 0.0 |
| 2026-07-16 | Issa Mohamed Khairie | A · Grant / award | Common Stock | 7857.0 | 0.0 |
| 2026-07-16 | Issa Mohamed Khairie | S · Sale | Common Stock | 1093.0 | 115.01 |
| 2026-07-16 | Issa Mohamed Khairie | A · Grant / award | Performance Shares | 19643.0 | 0.0 |
| 2026-07-16 | Issa Mohamed Khairie | A · Grant / award | Employee Stock Option (right to buy) | 33918.0 | 0.0 |
| 2026-07-16 | Tray Thomas | A · Grant / award | Common Stock | 2834.0 | 0.0 |
| 2026-07-16 | Tray Thomas | A · Grant / award | Employee Stock Option (right to buy) | 4079.0 | 0.0 |
| 2026-07-16 | Stein Steven H | S · Sale | Common Stock | 1877.0 | 114.73 |
| 2026-07-16 | Stein Steven H | A · Grant / award | Common Stock | 9798.0 | 0.0 |
| 2026-07-16 | Stein Steven H | A · Grant / award | Performance Shares | 24496.0 | 0.0 |
| 2026-07-16 | Stein Steven H | A · Grant / award | Employee Stock Option (right to buy) | 42298.0 | 0.0 |
| 2026-07-16 | Meury William | A · Grant / award | Common Stock | 26807.0 | 0.0 |
| 2026-07-16 | Meury William | A · Grant / award | Employee Stock Option (right to buy) | 77148.0 | 0.0 |
| 2026-07-16 | Meury William | A · Grant / award | Performance Shares | 80421.0 | 0.0 |
| 2026-07-16 | CAGNONI PABLO J | A · Grant / award | Common Stock | 13403.0 | 0.0 |
| 2026-07-16 | CAGNONI PABLO J | A · Grant / award | Performance Shares | 33508.0 | 0.0 |
| 2026-07-16 | CAGNONI PABLO J | A · Grant / award | Employee Stock Option (right to buy) | 57861.0 | 0.0 |
| 2026-07-15 | Mayes Patrick A | F · Tax / exercise payment | Common Stock | 1512.0 | 115.09 |
| 2026-07-15 | Issa Mohamed Khairie | F · Tax / exercise payment | Common Stock | 1099.0 | 115.09 |
| 2026-07-15 | Tray Thomas | F · Tax / exercise payment | Common Stock | 1098.0 | 115.09 |
| 2026-07-15 | Stein Steven H | F · Tax / exercise payment | Common Stock | 3088.0 | 115.09 |
| 2026-07-15 | Stein Steven H | S · Sale | Common Stock | 28237.0 | 113.05 |
Identity & relationships
SEC issuer · 0000879169INCYTE CORP
- Legal Entity Identifier
- 549300Z4WN6JVZ3T4680
- GLEIF legal name
- INCYTE CORPORATION
- Entity / LEI registration status
- ACTIVE / LAPSED
- Reference data updated
- 2023-08-04T17:38:19Z
Search names and former names
View Wikidata identity and references ↗
- Incyte · alias · wikidata
- Incyte Corporation · alias · wikidata
- Incyte Inc. · alias · wikidata
- INCYTE INC · former SEC name · 2003-03-28 to 2003-03-28
- INCYTE GENOMICS INC · former SEC name · 2000-08-03 to 2003-02-25
- INCYTE PHARMACEUTICALS INC · former SEC name · 1994-06-07 to 2000-04-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $4.24B | $4.56B |
| 2023-12-31 | $3.70B | $4.09B |
| 2022-12-31 | $3.39B | $3.91B |
| 2021-12-31 | $2.99B | $3.71B |
| 2020-12-31 | $2.67B | $3.47B |
| 2019-12-31 | $2.16B | $2.84B |
| 2018-12-31 | $1.88B | $2.53B |
| 2017-12-31 | $1.54B | $2.11B |